glp-1 obesity drug news updates Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Comparing stories on the new
Description
#Pharmacology #ClinicalPharmacology #DrugDiscovery #PharmaResearch #ObesityTreatment #HealthcareInnovation #DrugSafety
Explore GLP-1 medications like Ozempic and Wegovy
Experts suggest a quick "rebound" effect in appetite and metabolism after stopping the drug, compounded by the stress of pregnancy
Struggling with constipation on GLP-1 medications like Ozempic or Wegovy
Researchers conducted a prospective single-center cohort study of adults with a BMI of 27 kg/m2 or higher using liraglutide (Victoza/Saxenda, Novo Nordisk) or semaglutide (Ozempic/Wegovy, Novo Nordisk)
Glucagon-like-peptide-1 receptor agonists (GLP-1s) have transformed weight management and treatment of chronic disease
